WT
CTMX icon

Whittier Trust’s CytomX Therapeutics CTMX Stock Holding History

Whittier Trust’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,200
Closed -$2.68K – 1552
2024
Q2 		$2.68K Sell
2,200
-4,404
-67% -$8.77K ﹤0.01% 1406
2024
Q1 		$14.4K Hold
6,604
– – ﹤0.01% 1204
2023
Q4 		$10.2K Hold
6,604
– – ﹤0.01% 1233
2023
Q3 		$8.45K Sell
6,604
-1,759
-21% -$2.77K ﹤0.01% 1298
2023
Q2 		$14.4K Hold
8,363
– – ﹤0.01% 1193
2023
Q1 		$12.5K Hold
8,363
– – ﹤0.01% 1255
2022
Q4 		$13.3K Hold
8,363
– – ﹤0.01% 1236
2022
Q3 		$12K Hold
8,363
– – ﹤0.01% 1302
2022
Q2 		$15K Sell
8,363
-2,645
-24% -$5.06K ﹤0.01% 1240
2022
Q1 		$29K Hold
11,008
– – ﹤0.01% 1106
2021
Q4 		$48K Hold
11,008
– – ﹤0.01% 982
2021
Q3 		$56K Hold
11,008
– – ﹤0.01% 904
2021
Q2 		$70K Hold
11,008
– – ﹤0.01% 871
2021
Q1 		$85K Hold
11,008
– – ﹤0.01% 812
2020
Q4 		$72K Hold
11,008
– – ﹤0.01% 776
2020
Q3 		$73K Hold
11,008
– – ﹤0.01% 758
2020
Q2 		$92K Hold
11,008
– – ﹤0.01% 690
2020
Q1 		$84K Hold
11,008
– – ﹤0.01% 695
2019
Q4 		$91K Hold
11,008
– – ﹤0.01% 718
2019
Q3 		$81K Hold
11,008
– – ﹤0.01% 734
2019
Q2 		$124K Hold
11,008
– – ﹤0.01% 615
2019
Q1 		$118K Hold
11,008
– – ﹤0.01% 622
2018
Q4 		$166K Hold
11,008
– – 0.01% 541
2018
Q3 		$204K Sell
11,008
-2,205
-17% -$50.2K 0.01% 512
2018
Q2 		$302K Hold
13,213
– – 0.01% 439
2018
Q1 		$376K Buy
+13,213
New +$377K 0.01% 413

Other funds holding CTMX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Whittier Trust's CTMX Position: Q3 2024 in Review

Whittier Trust sold out of CytomX Therapeutics (CTMX) in Q3 2024, closing a stake of 2,200 shares — an estimated $2.68K sold.

Whittier Trust first reported a position in CTMX in Q1 2018 and held it in 26 quarters. The position peaked at $376K in Q1 2018. 69 funds tracked by Wall St. Rank hold CTMX as of Q3 2024.

  • Whittier Trust reported no remaining CytomX Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Whittier Trust sold 2,200 CytomX Therapeutics shares in Q3 2024, an estimated $2.68K.
  • Whittier Trust first reported a position in CytomX Therapeutics in Q1 2018 and held it in 26 quarters.
  • Whittier Trust's CytomX Therapeutics position peaked at $376K in Q1 2018.
  • 69 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2024.

Based on Whittier Trust's 13F filing for Q3 2024, filed 21 Oct 2024.